Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Rhythm Biosciences Limited (RHY)
  6. Company Announcements

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.083

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$20 Appendix 4D - Half Yearly Report 1 Mar 2018 10:33AM $0.200 $0.083 $0.084 fallen by 58.50%
$20 Half Yearly Report and Accounts 27 Feb 2018 2:38PM $0.185 $0.083 $0.084 fallen by 55.14%
$20 Consultation with Major Diagnostic Labs Underway - Update 15 Feb 2018 9:47AM $0.190 $0.083 $0.084 fallen by 56.32%
$20 Rhythm reports reagent development update 7 Feb 2018 11:59AM $0.190 $0.083 $0.084 fallen by 56.32%
$20 Quarterly report and Appendix 4C 31 Jan 2018 8:57AM $0.230 $0.083 $0.084 fallen by 63.91%
$20 CSIRO and Rhythm Commence Development of Key Reagents 24 Jan 2018 10:39AM $0.230 $0.083 $0.084 fallen by 63.91%
$20 CSIRO to assist Rhythm Biosciences develop key reagents 9 Jan 2018 9:59AM $0.270 $0.083 $0.084 fallen by 69.26%
$20 Becoming a substantial holder 7 Dec 2017 9:57AM n/a $0.083 $0.084 n/a
$20 Becoming a substantial holder 7 Dec 2017 9:57AM n/a $0.083 $0.084 n/a
$20 Appendix 3X - Lockett 6 Dec 2017 5:03PM n/a $0.083 $0.084 n/a
$20 Appendix 3X - Tanner 6 Dec 2017 5:02PM n/a $0.083 $0.084 n/a
$20 Appendix 3X - Panaccio 6 Dec 2017 5:01PM n/a $0.083 $0.084 n/a
$20 Appendix 3X - White 6 Dec 2017 4:59PM n/a $0.083 $0.084 n/a
$20 Corporate Governance Statement 6 Dec 2017 4:58PM n/a $0.083 $0.084 n/a
$20 Audited Special Purpose Report 1/6/17 to 30/6/17 6 Dec 2017 4:57PM n/a $0.083 $0.084 n/a
$20 Audited Special Purpose Report 1/7/17 to 31/8/17 6 Dec 2017 4:56PM n/a $0.083 $0.084 n/a
$20 Securities Trading Policy 6 Dec 2017 4:50PM n/a $0.083 $0.084 n/a
$20 Performance Rights Plan 6 Dec 2017 4:49PM n/a $0.083 $0.084 n/a
$20 Employee Security Ownership Plan 6 Dec 2017 4:48PM n/a $0.083 $0.084 n/a
$20 Constitution 6 Dec 2017 4:45PM n/a $0.083 $0.084 n/a
$20 Top 20 Shareholders 6 Dec 2017 4:44PM n/a $0.083 $0.084 n/a
$20 Distribution Schedule 6 Dec 2017 4:43PM n/a $0.083 $0.084 n/a
$20 Pre-quotation Disclosure 6 Dec 2017 4:41PM n/a $0.083 $0.084 n/a
$20 Appendix 1A and Information Form and Checklist 6 Dec 2017 4:40PM n/a $0.083 $0.084 n/a
$20 Replacement Prospectus 6 Dec 2017 4:39PM n/a $0.083 $0.084 n/a

401 - 425 of 427 results

Page 17 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.